Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Ulf Dettmer, Andrew J. Newman, Frank Soldner, Eric S. Luth, Nora C. Kim, Victoria E. Von Saucken, John B. Sanderson, Rudolf Jaenisch, Tim Bartels, Dennis Selkoe

Research output: Contribution to journalArticlepeer-review

228 Scopus citations

Abstract

β-Sheet-rich α-synuclein (αS) aggregates characterize Parkinson's disease (PD). αS was long believed to be a natively unfolded monomer, but recent work suggests it also occurs in α-helix-rich tetramers. Crosslinking traps principally tetrameric αS in intact normal neurons, but not after cell lysis, suggesting a dynamic equilibrium. Here we show that freshly biopsied normal human brain contains abundant αS tetramers. The PD-causing mutation A53T decreases tetramers in mouse brain. Neurons derived from an A53T patient have decreased tetramers. Neurons expressing E46K do also, and adding 1-2 E46K-like mutations into the canonical αS repeat motifs (KTKEGV) further reduces tetramers, decreases αS solubility and induces neurotoxicity and round inclusions. The other three fPD missense mutations likewise decrease tetramer:monomer ratios. The destabilization of physiological tetramers by PD-causing missense mutations and the neurotoxicity and inclusions induced by markedly decreasing tetramers suggest that decreased α-helical tetramers and increased unfolded monomers initiate pathogenesis. Tetramer-stabilizing compounds should prevent this.

Original languageEnglish (US)
Article number7314
JournalNature communications
Volume6
DOIs
StatePublished - Jun 16 2015
Externally publishedYes

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation'. Together they form a unique fingerprint.

Cite this